<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775878</url>
  </required_header>
  <id_info>
    <org_study_id>CN-08JMink-01</org_study_id>
    <nct_id>NCT01775878</nct_id>
  </id_info>
  <brief_title>Diabetes Care Management Trial of Telemetric Monitoring</brief_title>
  <acronym>TELEGAP</acronym>
  <official_title>A Randomized Study Comparing Usual Diabetes Care Management to Telemetric Home-based Monitoring of Glucose and Blood Pressure in Patients With Diabetes (TELEGAP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Samsung Electronics</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a two-arm, parallel-comparison, single-blind, randomized controlled trial, and
      will be offered to Kaiser Permanente members aged 18 - 75 years old who present to the Santa
      Rosa Diabetes Care Management Center with Type 2 diabetes mellitus. Participants will be
      randomly assigned to one of two treatment arms. The telemedicine group or the group receiving
      usual care (the control group).

      This study hopes to show the usefulness of this telemonitoring technology and more
      specifically, to assess whether this device improves markers of control of diabetes, glycemic
      control, and cardiovascular risk factors
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">January 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fructosamine</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change from baseline to 6 weeks in serum fructosamine levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>glycosylated hemoglobin</measure>
    <time_frame>6 months</time_frame>
    <description>change from baseline to 6 months in serum HbA1c levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood pressure</measure>
    <time_frame>6 weeks and 6 months</time_frame>
    <description>goal of systolic &lt; 130 mmHg and diastolic &lt; 70 mmHg</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">254</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm received usual care from the diabetes care managers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telemonitoring Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm received a telemonitoring device installed in their homes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telemonitoring Device</intervention_name>
    <description>Telemonitoring device was installed in patients' homes</description>
    <arm_group_label>Telemonitoring Device</arm_group_label>
    <other_name>Samsung Health Diary</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 - 75 years old,

          -  diagnosis of type 2 diabetes mellitus for at least 1 month,

          -  eligible for and referred to the diabetes care management program,

          -  HbA1c values in the range: 7.5% to 10.5%.

        Exclusion Criteria:

          -  Weight &gt; 330 lbs,

          -  estimated glomerular filtration rate (GFR) &lt; 45,

          -  unstable coronary artery disease,

          -  severe peripheral vascular disease which restricted exercise,

          -  end-stage liver disease,

          -  undergoing treatment for cancer,

          -  pregnant or not using appropriate birth control,

          -  no broadband internet access in their homes.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry Minkoff, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2013</study_first_submitted>
  <study_first_submitted_qc>January 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2013</study_first_posted>
  <last_update_submitted>January 23, 2013</last_update_submitted>
  <last_update_submitted_qc>January 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>HbA1c</keyword>
  <keyword>Fructosamine</keyword>
  <keyword>Blood Pressure</keyword>
  <keyword>Telemonitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>January 6, 2015</submitted>
    <returned>January 12, 2015</returned>
    <submitted>October 1, 2015</submitted>
    <returned>October 30, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

